Our scientists have developed a first-in-class solid form of nitric oxide, which can be used in gels, ointments, or creams, among many other forms.
The more we explore its uses, the more possibilities we uncover to treat critically under-treated medical conditions. Novan’s berdazimer sodium product candidates have been safely studied in nearly 3,000 patients since 2011.
Read About Our Safety
We have published extensively about the results of our clinical trials. Read more about the safety and efficacy of nitric oxide-based product candidates: